Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation
Autor: | Agnieszka Szymczyk, Marek Hus, Waldemar Tomczak, Beata Ostrowska, Sebastian Rybski, Anna Dąbrowska-Iwanicka, Tomasz Wróbel, Magdalena Olszewska-Szopa, Jan Walewski, Joanna Romejko-Jarosinska, Katarzyna Domanska-Czyz |
---|---|
Rok vydání: | 2021 |
Předmět: |
Cancer Research
medicine.medical_specialty business.industry viruses Castleman disease Castleman Disease virus diseases Antibodies Monoclonal Hematology medicine.disease Dermatology Siltuximab chemistry.chemical_compound Oncology chemistry immune system diseases hemic and lymphatic diseases medicine Humans Poland Multicentric Castleman Disease business |
Zdroj: | Leukemialymphoma. 62(12) |
ISSN: | 1029-2403 |
Popis: | Castleman disease (CD) was first described in the 1954 by Benjamin Castleman as a rare nonmalignant lymphoproliferative disorder [1]. Multicentric CD (MCD) involves multiple regions of enlarged lym... |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |